UPDATE 2-FDA approves J&J advanced prostate cancer drug | Reuters
Links shared publicly online about this topic.
- 331total visits
UPDATE 2-FDA approves J&J advanced prostate cancer drug | Reuters
View full resource at reuters.com
Tags: Cancer, Cancer Medication, Prostate Cancer, Prostate Cancer Medication, Prostate, Men's Health, FDA, Johnson & Johnson
Most Recently Shared on April 29, 2011 at 11:51 pm By:
FDA approves J&J advanced prostate cancer drug abiraterone. http://ow.ly/4K7F4
Also Shared By:
RT @AIDSmeds Just Updated : A printable drug chart of all approved #HIV medication http://t.co/tuF9HTUO #AIDS
aidsmeds.com — “RT @AIDSmeds Just Updated : A printable drug chart of all approved #HIV medication http://t.co/tuF9HTUO #AIDS” View full resource at aidsmeds.com
Most Recently Shared on May 1, 2012 at 2:25 pm By:
RT @AIDSmeds Just Updated : A printable drug chart of all approved #HIV medication http://t.co/tuF9HTUO #AIDS
Roche - Media: News and Press Releases
roche.com — “Press releases, media archive with backgrounders, photo and video material. Subscribe to our events podcast and regular updates via RSS-feed.” View full resource at roche.com
Most Recently Shared on September 1, 2011 at 8:58 am By:
For journalists: EU approval of medicine for first-line use in a genetically distinct type of #lungcancer http://t.co/wW6J6n8
UPDATE 1-J&J pain drug Nucynta ER gets FDA nod | Reuters
reuters.com — “* Nucynta ER is the extended release version of Nucynta * Approved with a risk evaluation and mitigation strategy (Follows alerts) Aug 26 (Reuters) - Johnson and Johnson unit JanssenPharmaceuticals” View full resource at reuters.com
Most Recently Shared on August 29, 2011 at 7:46 pm By:
Women In Pain Health Organization
Janssen's extended-release Nucynta is approved by FDA... http://t.co/jXqFTXY
NCI Cancer Bulletin for July 26, 2011 - National Cancer Institute
cancer.gov — “NCI Cancer Bulletin for July 26, 2011 - National Cancer Institute” View full resource at cancer.gov
Most Recently Shared on July 27, 2011 at 9:15 pm By:
NCI Cancer Bulletin Health News
FDA Update: Advisory panel recommends accelerated approval for brentuximab for 2 types of lymphoma http://j.mp/r6vRw6
FDA Approves Genetically Modified Grass: A Blow to the Organic Movement - Fort Lauderdale Organic Food | Examiner.com
examiner.com — “Just as sneakily as it approved genetically modified corn, soy, and various other plants, the FDA cleared the way for genetically modified Kentucky bluegrass ma” View full resource at examiner.com
Most Recently Shared on July 10, 2011 at 6:51 pm By:
Shalona Anuj, PhD PhD, Doctor, Organic Advocate, and Skin and Beauty
FDA Approves Genetically Modified Grass: A Blow to the Organic Movement http://bit.ly/mW69j2
UPDATE 2-U.S. advisers back Shire drug for rare disease | Reuters
reuters.com — “* Shire drug safe, effective for angioedema - FDA panel * Panel also says drug, Firazyr, safe for self-injection * FDA to decide on drug approval by Aug. 25 (Adds company, panelist comment, share” View full resource at reuters.com
Most Recently Shared on June 24, 2011 at 12:18 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
U.S. advisers back Shire drug, Firazyr for hereditary angioneurotic edema (HAE) http://goo.gl/jIIfN
Eli Lilly and Company - FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label
newsroom.lilly.com — “Eli Lilly and Company - FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label” View full resource at newsroom.lilly.com
Most Recently Shared on June 8, 2011 at 10:31 pm By:
FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label http://bit.ly/jZ4a7v
UPDATE 4-J&J to seek approval for 11 new drugs by 2015 | Reuters
reuters.com — “* Aims to seek approval of Alzheimer's drug in 2012-2013 * To boost investments in emerging markets * 7 launches seen in Japan this year * Shares fall 0.4 percent (Adds analyst comment, details” View full resource at reuters.com
Most Recently Shared on May 26, 2011 at 1:30 pm By:
John Carroll Health Communicator
J&J plans to introduce 11 new drugs by 2015. J&J has real skill at buying companies and programs.Will that get harder? http://reut.rs/jEBjI3
UPDATED: J&J is on a roll as drug deals deliver blockbuster approvals - FierceBiotech
fiercebiotech.com — “J&J never has won much praise for its science. The pharma giant, though, can spot a promising treatment in the pipeline, which it proved two years ago when it paid a billion dollars to buy up Read more...” View full resource at fiercebiotech.com
Most Recently Shared on May 23, 2011 at 1:06 pm By:
John Carroll Health Communicator
J&J is on a roll as drug deals deliver blockbuster approvals http://bit.ly/kMEhCp
Update to Fuzeon (Enfuvirtide) Label Regarding Incidence of Bacterial Pneumonia - The Body
thebody.com — “Updates to the Warnings and Precautions, Pneumonia subsection of the Fuzeon (enfuvirtide) package insert were approved on April 28, 2011 in response to ...” View full resource at thebody.com
Most Recently Shared on May 9, 2011 at 1:01 pm By:
Update to Fuzeon (Enfuvirtide) Label Regarding Incidence of Bacterial Pneumonia http://bit.ly/j6NiEU #hiv #aids #t-20 #fda
UPDATE 1-Vivus to submit Qnexa application as limited indication, shares up | Reuters
reuters.com — “* Says decided goals of Qnexa study with FDA * Plans to resubmit Qnexa marketing approval in Q4 as lmtdindication * Q1 loss per shr $0.12 vs est $0.15 * Shares up 6 pct after-market (Follows alerts)” View full resource at reuters.com
Most Recently Shared on May 3, 2011 at 11:19 am By:
John Carroll Health Communicator
Vivus shares got a little boost with its plan to submit a new, much more narrowly defined app for its obesity drug. http://reut.rs/j4eUxT
Medical News: FDA Updates PML Risk Info for Natalizumab - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “As expected, the FDA has approved new label language for the multiple sclerosis drug natalizumab (Tysabri) with additional detail on the risks of progressive multifocal leukoencephalopathy (PML).” View full resource at medpagetoday.com
Most Recently Shared on April 22, 2011 at 8:31 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday FDA Updates PML Risk Info for Natalizumab http://bit.ly/i6ZA0J #medical #Health
CMS Wants To 'Refresh' Health Plan Information on Healthcare.gov - iHealthBeat
ihealthbeat.org — “CMS is asking the White House Office of Management and Budget to quickly review its plan to collect updated information from health insurance companiesfor the Healthcare.gov website. The website, mandated by the federal health reform law, aims to provide consumers with information about their health plan options. Modern Healthcare.” View full resource at ihealthbeat.org
Most Recently Shared on March 28, 2011 at 7:04 pm By:
iHealthBeat.org Health Organization
CMS Wants To 'Refresh' Health Plan Information on Healthcare.gov - http://bit.ly/hGI0jM
Radient Pharmaceuticals Receives Update EU Certification | IVD Technology
ivdtechnology.com — “Radient Pharmaceuticals Corp. (RPC) has received CE Mark approval from the European Union (EU) for the use of its Onko-Sure IVD cancer test as a pan tumor marker for cancer.” View full resource at ivdtechnology.com
Most Recently Shared on January 20, 2011 at 6:55 pm By:
IVD Technology Health Magazine
Radient Pharmaceuticals Receives Update EU Certification http://tinyurl.com/4z68j54
Advertisement
Prostate Cancer
@prostatecancer_
FDA approves J&J advanced prostate cancer drug http://bit.ly/mMYcsn
1 year ago...